INTS vs TOST
Intensity Therapeutics, Inc. Common stock (INTS) versus Toast Inc (TOST) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Toast Inc (TOST) is a software - infrastructure company listed on US.
INTS does not have a complete income-statement cache yet.
Latest reported TOST revenue for 2024-12-31 was $4.96B. Net income was $19.0M. Revenue was up 28.3% from 2023-12-31 to 2024-12-31. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
INTS currently screens at market cap $7.7M. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
Not investment advice. Open the INTS and TOST stock pages for the full models.
Not investment advice.